Ian F. Smith
2010
In 2010, Ian F. Smith earned a total compensation of $3.1M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 66% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $459,000 |
|---|---|
| Option Awards | $1,688,073 |
| Salary | $491,220 |
| Stock Awards | $471,759 |
| Other | $12,429 |
| Total | $3,122,481 |
Smith received $1.7M in option awards, accounting for 54% of the total pay in 2010.
Smith also received $459K in non-equity incentive plan, $491.2K in salary, $471.8K in stock awards and $12.4K in other compensation.
Rankings
In 2010, Ian F. Smith's compensation ranked 1,890th out of 10,439 executives tracked by ExecPay. In other words, Smith earned more than 81.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,890 out of 10,439 | 82nd |
Division Manufacturing | 660 out of 3,838 | 83rd |
Major group Chemicals And Allied Products | 124 out of 921 | 87th |
Industry group Drugs | 71 out of 680 | 90th |
Industry Pharmaceutical Preparations | 54 out of 481 | 89th |
Source: SEC filing on April 4, 2013.
Smith's colleagues
We found five more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2010.
2010
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2010
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2010
Kenneth Boger
Vertex Pharmaceuticals
Chief Legal Officer
2010
Amit Sachdev
Vertex Pharmaceuticals
Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada
2010
Nancy Wysenski
Vertex Pharmaceuticals